Beyond Hormone Therapy for Prostate Cancer with PARP inhibitors

11Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

In this issue of Cancer Cell, Brenner et al. describe that the poly-(ADP) ribose polymerase (PARP) may mediate ERG function and that PARP blockade has antitumor activity in ETS gene-rearranged prostate cancer models. These data support the clinical evaluation of PARP inhibitors for treating ETS gene-rearranged prostate cancers. © 2011 Elsevier Inc.

Cite

CITATION STYLE

APA

Sebastian de Bono, J., Sandhu, S., & Attard, G. (2011, May 17). Beyond Hormone Therapy for Prostate Cancer with PARP inhibitors. Cancer Cell. https://doi.org/10.1016/j.ccr.2011.05.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free